COMP <GO>
LEVI vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
Levi Strauss & Co (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: LEVI 7
— PG 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PG
LAST: $22.61 (+4.53%) • MKT CAP: $8.67B
balance-sheet
2.97
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEVI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEVI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.70% | 51.20% | +10.50 | LEVI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.90% | 25.40% | -4.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | 16.2x | -5.90 | LEVI | /valuation <GO> |
| Free Cash Flow Yield | 3.55% | 3.77% | -0.22 | PG | /fcf-yield <GO> |
| Operating Margin | 10.80% | 24.30% | -13.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 19.00% | -10.60 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.10% | 0.30% | +3.80 | LEVI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.46% | 2.65% | -0.19 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.97 | 5.59 | -2.62 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | LEVI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.4 | 60.3 | +9.10 | LEVI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.87 | +0.23 | LEVI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 21.7x | -6.40 | LEVI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.67B | $372.21B | -$363.54B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEVI REV | PG REV | LEVI GROSS % | PG GROSS % | LEVI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.28B | $84.28B | 61.7% | 51.2% | $308.2M | $14.04B |
| FY 2024 | $6.03B | $84.04B | 60.6% | 51.4% | $670.9M | $16.52B |
| FY 2023 | $5.84B | $82.01B | — | — | $172.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEVI // BETA 1.10
PG // BETA 0.87